Published in HPB (Oxford) on January 10, 2012
Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J (2013) 1.24
Helicobacter pylori infection and diabetes: is it a myth or fact? World J Gastroenterol (2014) 1.08
From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol (2015) 0.90
Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma. EBioMedicine (2016) 0.87
The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. Asian Pac J Cancer Prev (2015) 0.86
Effects of Helicobacter pylori γ-glutamyltranspeptidase on apoptosis and inflammation in human biliary cells. Dig Dis Sci (2012) 0.84
Helicobacter pylori infection does not promote hepatocellular cancer in a transgenic mouse model of hepatitis C virus pathogenesis. Gut Microbes (2013) 0.81
Molecular analysis of Helicobacter pylori virulent-associated genes in hepatobiliary patients. HPB (Oxford) (2012) 0.81
Chronic Opisthorchis viverrini Infection Changes the Liver Microbiome and Promotes Helicobacter Growth. PLoS One (2016) 0.80
A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand. PLoS Negl Trop Dis (2016) 0.77
Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma? Parasitol Int (2016) 0.76
Association of Fasciola hepatica Infection with Liver Fibrosis, Cirrhosis, and Cancer: A Systematic Review. PLoS Negl Trop Dis (2016) 0.76
Helicobacter pylori in Cholecystectomy Specimens-Morphological and Immunohistochemical Assessment. J Clin Diagn Res (2016) 0.75
Coinfection with Helicobacter pylori and Opisthorchis viverrini Enhances the Severity of Hepatobiliary Abnormalities in Hamsters. Infect Immun (2017) 0.75
Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease. Sci Rep (2017) 0.75
Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics? Indian J Endocrinol Metab (2015) 0.75
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol (1998) 5.07
EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol (2009) 4.45
Liver fluke induces cholangiocarcinoma. PLoS Med (2007) 3.89
Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol (1997) 2.89
Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res (1998) 2.34
Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer (2002) 1.78
Campylobacter pylori, acid, and bile. J Clin Pathol (1987) 1.51
Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer (1994) 1.51
A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology (2011) 1.29
Current status of Helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan. Curr Microbiol (2000) 1.24
Coccoid form of Helicobacter pylori as a morphological manifestation of cell adaptation to the environment. Appl Environ Microbiol (2007) 1.16
Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia. Asian Pac J Cancer Prev (2010) 1.13
Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol (2004) 1.12
Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol (2003) 1.11
Virulence of water-induced coccoid Helicobacter pylori and its experimental infection in mice. World J Gastroenterol (2003) 1.10
Bacteria closely resembling Helicobacter pylori detected immunohistologically and genetically in resected gallbladder mucosa. J Gastroenterol (1996) 1.10
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol (2004) 1.08
Helicobacter species and liver diseases: association or causation? Lancet Infect Dis (2008) 1.08
Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther (2002) 1.03
Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis (2002) 1.01
Helicobacter infection in hepatocellular carcinoma tissue. World J Gastroenterol (2006) 0.98
Two-year follow-up of Helicobacter pylori infection in C57BL/6 and Balb/cA mice. APMIS (2003) 0.97
Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther (2004) 0.96
Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig Liver Dis (2003) 0.96
Helicobacter species in the intestinal mucosa of patients with ulcerative colitis. J Clin Microbiol (2004) 0.95
Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease. Helicobacter (2009) 0.94
Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases. World J Gastroenterol (2006) 0.92
Helicobacter pylori promotes hepatic fibrosis in the animal model. Lab Invest (2009) 0.91
DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma. Dig Liver Dis (2007) 0.90
Role of cagA-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells. Dig Dis Sci (2010) 0.88
High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma. J Cancer Res Clin Oncol (2004) 0.84
Tract microflora in Saudi patients with cholelithiasis. Trop Med Int Health (2001) 0.80
Detection of VacA gene specific for Helicobactor pylori in hepatocellular carcinoma and cholangiocarcinoma specimens of Thai patients. Southeast Asian J Trop Med Public Health (2007) 0.79
Patients with uncomplicated cholelithiasis acidify bile normally. Dig Dis Sci (1992) 0.79
Helicobacter pylori infection, iNOS, and gastric cancer: the impact of another possible link. J Surg Oncol (2007) 0.77
Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet (2012) 3.63
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol (2013) 2.44
Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci (2009) 2.27
The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int (2011) 2.15
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet (2013) 2.15
A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis (2012) 2.09
A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis (2012) 1.78
Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide (2004) 1.54
Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini. PLoS Negl Trop Dis (2010) 1.46
Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer (2005) 1.45
A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells. PLoS Pathog (2009) 1.45
Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. Hepatology (2006) 1.40
Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis (2007) 1.37
Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini. BMC Genomics (2007) 1.35
The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics (2010) 1.35
Soil-transmitted helminthiasis in Laos: a community-wide cross-sectional study of humans and dogs in a mass drug administration environment. Am J Trop Med Hyg (2012) 1.33
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol (2005) 1.32
A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis (2012) 1.26
Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis (2004) 1.25
Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J (2013) 1.24
Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia. Asian Pac J Cancer Prev (2010) 1.13
Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Carcinogenesis (2011) 1.13
Opisthorchis viverrini: the carcinogenic human liver fluke. World J Gastroenterol (2008) 1.12
High prevalence of Opisthorchis viverrini infection in reservoir hosts in four districts of Khon Kaen Province, an opisthorchiasis endemic area of Thailand. Parasitol Int (2011) 1.08
Characterization of the antioxidant enzyme, thioredoxin peroxidase, from the carcinogenic human liver fluke, Opisthorchis viverrini. Mol Biochem Parasitol (2008) 1.08
8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini. Biochem Biophys Res Commun (2003) 1.06
iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel. Int J Cancer (2006) 1.06
Cathepsin F cysteine protease of the human liver fluke, Opisthorchis viverrini. PLoS Negl Trop Dis (2009) 1.06
A review of parasitic zoonoses in a changing Southeast Asia. Vet Parasitol (2011) 1.06
Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int (2011) 1.04
Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte. Parasitol Int (2010) 1.03
Epidemiology of antimicrobial resistance in Salmonella isolated from pork, chicken meat and humans in Thailand. Southeast Asian J Trop Med Public Health (2005) 1.02
Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis. Cancer Epidemiol Biomarkers Prev (2008) 1.00
Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis (2012) 1.00
Hepatobiliary changes, antibody response, and alteration of liver enzymes in hamsters re-infected with Opisthorchis viverrini. Exp Parasitol (2004) 1.00
Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol (2005) 1.00
Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Tumour Biol (2013) 0.98
Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol (2008) 0.98
Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells. J Cancer Res Clin Oncol (2006) 0.98
Infection with the carcinogenic human liver fluke, Opisthorchis viverrini. Mol Biosyst (2011) 0.97
Retracted Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma. Clin Biochem (2012) 0.97
Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis. Anticancer Res (2006) 0.97
A cross-sectional study of Taenia solium in a multiple taeniid-endemic region reveals competition may be protective. Am J Trop Med Hyg (2012) 0.97
Comparative histopathology of Opisthorchis felineus and Opisthorchis viverrini in a hamster model: an implication of high pathogenicity of the European liver fluke. Parasitol Int (2011) 0.96
Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol (2011) 0.95
Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. Cancer Lett (2003) 0.95
Asparaginyl endopeptidase from the carcinogenic liver fluke, Opisthorchis viverrini, and its potential for serodiagnosis. Int J Infect Dis (2008) 0.95
Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis. Free Radic Biol Med (2013) 0.93
Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells. J Cancer Res Clin Oncol (2008) 0.93
Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. Chemotherapy (2008) 0.93
Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. World J Gastroenterol (2005) 0.93
Rapid detection of Opisthorchis viverrini copro-DNA using loop-mediated isothermal amplification (LAMP). Parasitol Int (2011) 0.93
Carcinogenic liver fluke Opisthorchis viverrini oxysterols detected by LC-MS/MS survey of soluble fraction parasite extract. Parasitol Int (2013) 0.93
High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis. World J Gastroenterol (2012) 0.93
Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur J Cancer (2008) 0.92
Annexin A1: A new immunohistological marker of cholangiocarcinoma. World J Gastroenterol (2013) 0.91
A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases. PLoS Negl Trop Dis (2012) 0.91
Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B. Cell Microbiol (2010) 0.91
Descending colon obstruction caused by a parietocolic band: a case report. J Med Assoc Thai (2002) 0.91
Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Cancer (2007) 0.91
RNA interference targeting cathepsin B of the carcinogenic liver fluke, Opisthorchis viverrini. Parasitol Int (2011) 0.91
Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis. Cancer Lett (2002) 0.90
Evaluation of liver fluke recombinant cathepsin B-1 protease as a serodiagnostic antigen for human opisthorchiasis. Parasitol Int (2011) 0.90
Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. Mol Carcinog (2006) 0.90
Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Rep (2011) 0.89
Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity. Int J Biochem Cell Biol (2008) 0.89
Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev (2011) 0.89
Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. Asian Pac J Cancer Prev (2014) 0.88
Role of cagA-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells. Dig Dis Sci (2010) 0.88
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma. Cancer Lett (2005) 0.88
MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma. World J Gastroenterol (2005) 0.88
Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis. World J Gastroenterol (2006) 0.88
Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma. Cancer Sci (2009) 0.88
Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer (2003) 0.88
Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin. Biol Pharm Bull (2012) 0.88
Effect of light intensity on Opisthorchis viverrini cercarial shedding levels from Bithynia snails--a preliminary study. Parasitol Int (2011) 0.87
Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis. PLoS Negl Trop Dis (2013) 0.86
Characterization of cysteine proteases from the carcinogenic liver fluke, Opisthorchis viverrini. Parasitol Res (2007) 0.86
Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma. Asian Pac J Cancer Prev (2012) 0.86
The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. Asian Pac J Cancer Prev (2015) 0.86
Molecular characterization of a tetraspanin from the human liver fluke, Opisthorchis viverrini. PLoS Negl Trop Dis (2012) 0.86
Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma. Free Radic Biol Med (2012) 0.86
Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma. Hum Pathol (2012) 0.86
Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev (2013) 0.85
Serial analyses of postmortem changes in human skeletal muscle: A case study of alterations in proteome profile, histology, electrolyte contents, water composition, and enzyme activity. Proteomics Clin Appl (2008) 0.85